Search Results - Yu. N. Belenkov

Refine Results
  1. 1

    Evidence-based approaches to comparing the effectiveness of modern cardiology interventions: trends, bias and prospects by S. R. Gilyarevsky, Yu. N. Belenkov

    Published 2020-09-01

    The article discusses the limitations of the evidence from observational studies. Modern approaches to reducing bias in observational studies are discussed in detail, in particular, propensity score matching, which has become popular in recent years. The main differences between randomized and obser...

    Full description

    Get full text
    Article
  2. 2

    Enhanced external counterpulsation in the management of patients with ischemic heart failure: long-term impact on clinical outcomes by A. S. Lishuta, E. V. Privalova, Yu. N. Belenkov

    Published 2024-09-01

    Aim. To study the long-term effect of complex therapy with enhanced external counterpulsation (EECP) on clinical parameters and outcomes in patients with stable coronary artery disease (CAD) complicated by heart failure (HF).Material and methods. The randomized trial EXCEL (Long-term Effects of enha...

    Full description

    Get full text
    Article
  3. 3

    New TABAs technique in coronary bifurcation stenosis treatment by T. A. Batyraliev, D. V. Fetser, Yu. N. Belenkov

    Published 1970-01-01

    Percutaneous coronary intervention (PCI) in coronary bifurcation stenosis is still regarded as technically complicated, due to the risk of lateral branch occlusion. Bifurcation stenosis is also characterised by higher intervention costs and restenosis incidence. Over the last 10 years, a range of ne...

    Full description

    Get full text
    Article
  4. 4

    Russian Study on Optimal Blood Pressure Reduction (ROSA 2). Two-year follow-up. What is the result? by Yu. N. Belenkov, I. E. Chazova, L. G. Ratova

    Published 2005-12-01

    Twenty centers from 19 Russian regions took part in ROSA 2, following the first ROSA study. Aim. In arterial hypertension (AH) patients, to compare efficacy, safety, and impact on cardiovascular event (CVE) incidence for two treatment strategies: intensive stepwise therapy with four classes of antih...

    Full description

    Get full text
    Article
  5. 5

    About the classification of heart failure by A. S. Galyavich, S. V. Nedogoda, G. P. Arutyunov, Yu. N. Belenkov

    Published 2023-09-01

    The article discusses the classification of heart failure (HF). A novel HF classification and its advantages over the existing ones are shown. Variants of approximate diagnoses are given in accordance with the novel HF classification.

    Get full text
    Article
  6. 6

    Left ventricular hypertrophy: renin4angiotensin system role by F. T. Ageev, A. G. Ovchinnikov, V. M. Serbul, Yu. N. Belenkov

    Published 2008-04-01

    The review presents modern views on pathogenetic mechanisms of myocardial hypertrophy, with the key role played by renin-angiotensin system (RAS) activation and hemodynamic overload. The authors analyze main structural and functional disturbances typical for and underlying the clinical manifestation...

    Full description

    Get full text
    Article
  7. 7

    Ischemic heart disease and reflux-esophagitis: complexities of the differential diagnosis and treatment. by Yu. N. Belenkov, Ye. V. Privalova, A. O. Yusupova, M. V. Kozhevnikova

    Published 2011-05-01

    The aim of review. To illuminate state-of-the-art of issue of ischemic heart disease and reflux-esophagitis combination and options of treatment of comorbide patients.Original positions. Ischemic heart disease (IHD) and reflux-esophagitis (RE) are one of the most frequent diseases of cardio-vascular...

    Full description

    Get full text
    Article
  8. 8

    Microcirculatory disorders in patients with coronary heart disease and type 2 diabetes by Yu. N. Belenkov, E. V. Privalova, A. A. Shchendrygina, I. S. Chekneva, T. V. Emelyanova

    Published 2014-12-01

    In patients with coronary artery disease (CAD) and those who suffer from second type diabetes mellitus micro vascular disorders was found. Diabetes is associated with an increased risk of cardiovascular events. It might be due to micro vascular changes. We hypothesized that patients with CAD and CAD...

    Full description

    Get full text
    Article
  9. 9

    Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study by A. S. Lishuta, O. A. Slepova, N. S. Nikolaeva, E. V. Privalova, Yu. N. Belenkov

    Published 2024-06-01

    Aim. To study the long-term effect of complex therapy with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, and systolic cardiac function in patients with stable coronary artery disease (CAD) complicated by heart failure (HF).Material and methods. Open randomized stu...

    Full description

    Get full text
    Article
  10. 10

    Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease by T. A. Batyraliev, D. V. Fetzer, D. V. Preobrazhenskyi, A. Kochak, Yu. N. Belenkov

    Published 2011-08-01

    Aim. In a non-randomised study, to assess middle-term (9 months) effectiveness and safety of percutaneous coronary intervention (PCI) with “Ephesos II” stent implantation. Material and methods. The study included 41 patients, treated at the Sani Konukoglu Medical Centre, Gaziantep, Turkey. Results....

    Full description

    Get full text
    Article
  11. 11

    Medium-term Effects of Enhanced External Counterpulsation in the Structural and Functional Parameters of Blood Vessels in Patients with Coronary Artery Disease by K. S. Karaganov, O. A. Slepova, A. S. Lishuta, N. I. Solomakhina, Yu. N. Belenkov

    Published 2021-09-01

    Aim. To study the mid-term effects of enhanced external counterpulsation (EECP) in the structural and functional parameters of blood vessels, exercise tolerance and quality of life indicators in patients with verified coronary artery disease (CAD).Material and methods. Patients (n=70) with verified...

    Full description

    Get full text
    Article
  12. 12

    The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabe... by O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov

    Published 2022-07-01

    Aim. To study the effect of enhanced external counterpulsation (EECP) on the functional status, quality of life, structural and functional state of the vascular bed, and markers of glycemic control in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (DM).Material and methods....

    Full description

    Get full text
    Article
  13. 13

    CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN C... by E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov

    Published 2013-02-01

    One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD ris...

    Full description

    Get full text
    Article
  14. 14

    Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellit... by A. V. Zhito, A. O. Iusupova, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov

    Published 2020-01-01

    The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death, and the mortality rate from type 2 diabetes and it...

    Full description

    Get full text
    Article
  15. 15

    VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL by Yu. N. Belenkov, E. V. Privalova, Yu. A. Danilogorskaya, E. A. Zheleznykh, A. A. Shchendrygina

    Published 2012-06-01

    Risk factors are the cornerstone of the cardiovascular continuum concept. Arterial hypertension is one of major risk factors, which accounts for a substantial proportion of cardiovascular morbidity and mortality due to cardiovascular complications (CVC). The latter develop due to, among other reason...

    Full description

    Get full text
    Article
  16. 16

    Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus by Yu. N. Belenkov, E. V. Privalova, I. S. Chekneva, L. V. Knyazeva, N. S. Suleymanova, I. V. Vasilyeva

    Published 2011-02-01

    In patients with chronic heart failure (CHF), persistent neuro-humoral activation of sympatho-adrenal system and hyperglycaemia facilitate the activation of pro-cytokine inflammation component, as one of the pathophysiological mechanisms of endothelial dysfunction (ED). Aim. To study nebivolol effec...

    Full description

    Get full text
    Article
  17. 17

    POSSIBILITIES OF ENHANCED EXTERNAL COUNTERPULSATION USING IN CLINICAL PRACTICE by Z. A. Mamieva, A. S. Lishuta, Yu. N. Belenkov, E. V. Privalova, A. O. Yusupova, S. M. Rykova

    Published 2017-05-01

    Possibilities and prospects for the clinical use of enhanced external counterpulsation (EECP), which has long established itself throughout the world, are discussed in the article. Historical background, as well as the development stages of EECP for the treatment of patients with coronary heart dise...

    Full description

    Get full text
    Article
  18. 18

    Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure by A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov

    Published 2024-03-01

    Aim. To study the effect of various therapy regimens with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, indices of structural and functional state of cardiovascular system in patients with stable coronary artery disease (CAD) complicated by chronic heart failure (...

    Full description

    Get full text
    Article
  19. 19

    The Method of Enhanced External Counterpulsation in Clinical Practice by N. A. Nikolaeva, A. S. Lishuta, O. O. Voronkova, O. А. Slepova, Yu. A. Petukhova, Yu. N. Belenkov

    Published 2024-10-01

    Chronic non- infectious diseases represent an important medical and social problem for the healthcare system. Optimal pharmacotherapy is not always effective enough, and the use of surgical treatment methods is not possible in all patients. In addition, an important link in the comprehensive managem...

    Full description

    Get full text
    Article
  20. 20

    Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure by A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova, E. V. Privalova, Yu. N. Belenkov

    Published 2024-06-01

    Aim. To study the long-term effects of complex therapy with the addition of enhanced external counterpulsation (EECP) in patients with stable coronary artery disease (CAD) complicated by chronic heart failure (CHF).Material and methods. In the open randomized trial EXCEL (NCT05913778), 118 Patients...

    Full description

    Get full text
    Article